Sinus Infection Clinical Trial
Official title:
Epidemiological Study of Non-invasive Fungal Sinusitis as Presented in Sohag University Hospital
| Verified date | October 2021 |
| Source | Sohag University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
in this study, the investigators will collect data from patients with non-invasive fungal sinusitis to know what causes it
| Status | Enrolling by invitation |
| Enrollment | 70 |
| Est. completion date | August 2022 |
| Est. primary completion date | August 2022 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: - Patients with Acute fungal sinusitis. - Patients with chronic granulomatous sinusitis. - Patients with sinus mycetomas. Exclusion Criteria: - Immunocompromised patients. - invasive fungal sinusitis. |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Sohag University Hospital | Sohag |
| Lead Sponsor | Collaborator |
|---|---|
| Sohag University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | risk factors related to non-invasive fungal sinusitis | retrospective study assessed by Statistical Package for Social Sciences | 5 years study period from august 2016 to august 2021 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06076304 -
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis
|
Phase 4 | |
| Recruiting |
NCT03729258 -
Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.
|
Phase 3 | |
| Recruiting |
NCT05454072 -
Microbiota Transfer for Chronic Rhinosinusitis
|
N/A | |
| Enrolling by invitation |
NCT05954273 -
Maxillary Sinus Membrane Perforation Incidence During Osseodensification
|